Targeting Pathways Downstream of KRAS in Lung Adenocarcinoma

Pharmacogenomics - United Kingdom
doi 10.2217/pgs.14.108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd